494 related articles for article (PubMed ID: 24011030)
1. Erdheim-Chester Disease: a comprehensive review of the literature.
Mazor RD; Manevich-Mazor M; Shoenfeld Y
Orphanet J Rare Dis; 2013 Sep; 8():137. PubMed ID: 24011030
[TBL] [Abstract][Full Text] [Related]
2. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Curr Rheumatol Rep; 2014 Apr; 16(4):412. PubMed ID: 24532298
[TBL] [Abstract][Full Text] [Related]
3. Erdheim-Chester Disease: Case Report with Aggressive Multisystem Manifestations and Review of the Literature.
Alotaibi S; Alhafi O; Nasr H; Eltayeb K; Elyamany G
Case Rep Oncol; 2017; 10(2):501-507. PubMed ID: 28690524
[TBL] [Abstract][Full Text] [Related]
4. Erdheim-Chester disease.
Campochiaro C; Tomelleri A; Cavalli G; Berti A; Dagna L
Eur J Intern Med; 2015 May; 26(4):223-9. PubMed ID: 25865950
[TBL] [Abstract][Full Text] [Related]
5. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
[TBL] [Abstract][Full Text] [Related]
6. Erdheim-Chester disease.
Haroche J; Arnaud L; Cohen-Aubart F; Hervier B; Charlotte F; Emile JF; Amoura Z
Rheum Dis Clin North Am; 2013 May; 39(2):299-311. PubMed ID: 23597965
[TBL] [Abstract][Full Text] [Related]
7. [Erdheim-Chester disease (ECD), an inflammatory myeloid neoplasia].
Haroche J; Papo M; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
Presse Med; 2017 Jan; 46(1):96-106. PubMed ID: 27234902
[TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester disease (ECD): Case report, clinical and basic investigations, and review of literature.
Adawi M; Bisharat B; Bowirrat A
Medicine (Baltimore); 2016 Oct; 95(42):e5167. PubMed ID: 27759649
[TBL] [Abstract][Full Text] [Related]
9. Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.
Mazor RD; Manevich-Mazor M; Kesler A; Aizenstein O; Eshed I; Jaffe R; Pessach Y; Goldberg I; Sprecher E; Yaish I; Gural A; Ganzel C; Shoenfeld Y
BMC Med; 2014 Dec; 12():221. PubMed ID: 25434739
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
[TBL] [Abstract][Full Text] [Related]
12. [Erdheim-Chester disease].
Mazor RD; Shoenfeld Y
Harefuah; 2014 Jul; 153(7):389-91, 434, 433. PubMed ID: 25189027
[TBL] [Abstract][Full Text] [Related]
13. Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen.
Dai S; Su X; Liu WP; Wu Y
Cardiovasc Pathol; 2024; 70():107625. PubMed ID: 38417471
[TBL] [Abstract][Full Text] [Related]
14. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
Dasdelen S; Büschek F
Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
[TBL] [Abstract][Full Text] [Related]
15. Hypoalphalipoproteinemia and BRAF
Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
Cao XX; Sun J; Li J; Zhong DR; Niu N; Duan MH; Liang ZY; Zhou DB
Ann Hematol; 2016 Apr; 95(5):745-50. PubMed ID: 26858028
[TBL] [Abstract][Full Text] [Related]
17. Erdheim-Chester disease.
Brychtová M; Vlachová M; Gregorová J; Krejčí M; Adam Z; Ševčíková S
Klin Onkol; 2021; 34(6):434-439. PubMed ID: 34911328
[TBL] [Abstract][Full Text] [Related]
18. Erdheim-Chester disease: a comprehensive review.
Abdelfattah AM; Arnaout K; Tabbara IA
Anticancer Res; 2014 Jul; 34(7):3257-61. PubMed ID: 24982329
[TBL] [Abstract][Full Text] [Related]
19. BRAF-Mutated Erdheim-Chester Disease: Profound Response to Vemurafenib Visualized With Serial Multimodality Imaging.
Gray JCR; Kim J; Digianvittorio M; Feeley NK; Scheel PJ; Siegelman SS; Fishman EK; Rowe SP
J Natl Compr Canc Netw; 2020 Jun; 18(6):650-655. PubMed ID: 32502983
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Neuroimaging Manifestations of Erdheim-Chester Disease: A Review.
Garg N; Lavi ES
J Neuroimaging; 2021 Jan; 31(1):35-44. PubMed ID: 32920940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
